GO:1901137 carbohydrate derivative biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1901137 describes the chemical reactions and pathways that build carbohydrate derivatives, a broad class of molecules including sugar acids, sugar phosphates, amino sugars, and nucleotide sugars.
• These pathways are fundamental to cell surface engineering, energy storage, and structural integrity, with roles in taste perception and hemoglobin polymerization.
• Key enzymes include glycosyltransferases, epimerases, and kinases that modify sugar scaffolds, often using nucleotide sugars as donors.
• Dysregulation of carbohydrate derivative biosynthesis is linked to metabolic disorders, cancer, and infectious diseases, making it a target for therapeutic intervention.
• CRISPR-based models (knockout, knock-in, overexpression) enable precise dissection of these pathways in human cells.
• Understanding this process aids in sports nutrition, food science, and drug development, as seen with sucrose and pantethine research.
Description
Carbohydrate derivatives are molecules formed by modifying simple sugars through reactions such as phosphorylation, amination, acetylation, or conjugation to other biomolecules. The Gene Ontology term GO:1901137, carbohydrate derivative biosynthetic process, encompasses all biochemical pathways that result in the formation of these compounds. This term is essential for annotating genes involved in the synthesis of nucleotide sugars, sugar acids, amino sugars, and other derivatives that serve as building blocks for glycoproteins, glycolipids, and polysaccharides. Researchers studying cell surface chemistry, metabolic engineering, and disease mechanisms rely on this ontology term to systematically classify gene functions and interpret high-throughput data. The importance of carbohydrate derivative biosynthesis extends to diverse fields, from understanding taste perception of sugars to developing therapeutic strategies for metabolic and infectious diseases.
carbohydrate derivative biosynthetic process At A Glance
| GO ID | GO:1901137 |
|---|---|
| GO term | carbohydrate derivative biosynthetic process |
| Ontology | biological_process |
| Synonym | carbohydrate derivative anabolism; carbohydrate derivative biosynthesis; carbohydrate derivative formation; carbohydrate derivative synthesis |
| Major function | Synthesis of modified carbohydrates such as sugar phosphates, amino sugars, and nucleotide sugars |
| Related pathways | Glycolysis, pentose phosphate pathway, amino sugar metabolism, nucleotide sugar interconversion |
| Key enzymes | Glycosyltransferases, epimerases, kinases, mutases, and dehydrogenases |
| Cellular location | Cytosol, endoplasmic reticulum, Golgi apparatus, and mitochondria |
What Is GO:1901137?
GO:1901137, carbohydrate derivative biosynthetic process, is defined as the chemical reactions and pathways resulting in the formation of a carbohydrate derivative. A carbohydrate derivative is any molecule derived from a carbohydrate by chemical modification, such as oxidation, reduction, phosphorylation, or addition of amino or acetyl groups. This process includes the biosynthesis of sugar phosphates, sugar acids, amino sugars, nucleotide sugars, and other modified sugars. It is a biological process term in the Gene Ontology, with synonyms including carbohydrate derivative anabolism, biosynthesis, formation, and synthesis.
Why Is carbohydrate derivative biosynthetic process Important in Cell Biology?
Carbohydrate derivative biosynthetic processes are central to cellular metabolism, providing precursors for glycoproteins, glycolipids, and polysaccharides that mediate cell recognition, signaling, and structural integrity. Defects in these pathways can lead to metabolic disorders, immune dysfunction, and cancer, as altered glycosylation is a hallmark of tumor cells. Moreover, carbohydrate derivatives influence food properties and human health, as seen in studies on sucrose metabolism and advanced glycation end products. Understanding these pathways is therefore critical for developing diagnostics and therapeutics targeting glycosylation and metabolic diseases.
• Provides essential building blocks for glycoproteins and glycolipids that mediate cell-cell communication.
• Supports energy metabolism through intermediates like glucose-6-phosphate and UDP-glucose.
• Plays a role in taste perception, as structural relationships of sugars determine sweetness.
• Contributes to hemoglobin polymerization through glycosylation-related modifications.
• Involved in the mechanism of action of pantethine, a compound used for hyperlipidemia.
• Links to food science via the formation of 1,2-dicarbonyl compounds during heating.
• Affects sports performance through sucrose metabolism and glycogen synthesis.
• Dysregulation is associated with cancer, diabetes, and infectious diseases.
• Target for metabolic engineering to produce bioactive carbohydrates.
• Enables CRISPR-based functional studies of glycosylation genes.
What Happens During carbohydrate derivative biosynthetic process?
Activation of Sugar Precursors
In simple terms: Simple sugars are first activated by attaching them to nucleotide carriers like UDP or GDP.
The biosynthesis of carbohydrate derivatives often begins with the activation of monosaccharides through phosphorylation and nucleotidyl transfer. For example, glucose is converted to glucose-6-phosphate by hexokinase, then to UDP-glucose by UDP-glucose pyrophosphorylase. These activated sugars serve as donors for subsequent modifications. This step is crucial for channeling sugars into various derivative pathways, including those for glycoprotein synthesis.
Modification Reactions
In simple terms: Activated sugars undergo chemical changes such as amination, acetylation, or oxidation to become derivatives.
Once activated, sugars are modified by enzymes such as epimerases, dehydrogenases, and aminotransferases. For instance, UDP-N-acetylglucosamine is synthesized from UDP-glucose via a series of reactions involving oxidation, amination, and acetylation. These modifications generate the diversity of carbohydrate derivatives required for cellular functions. Such reactions are essential for producing amino sugars and sugar acids that participate in cell surface chemistry.
Polymerization and Conjugation
In simple terms: Modified sugars are linked together or attached to proteins and lipids to form complex glycoconjugates.
Carbohydrate derivatives can be polymerized into polysaccharides or conjugated to proteins and lipids in the endoplasmic reticulum and Golgi apparatus. Glycosyltransferases catalyze the transfer of sugar moieties from nucleotide sugars to acceptor molecules, forming glycoproteins and glycolipids. These glycoconjugates are vital for cell recognition, signaling, and structural integrity.
Regulation and Feedback
In simple terms: The process is controlled by enzymes and feedback loops to meet cellular demands.
Carbohydrate derivative biosynthesis is regulated at multiple levels, including enzyme expression, allosteric regulation, and substrate availability. For example, the hexosamine biosynthetic pathway is sensitive to nutrient status and influences protein glycosylation. Dysregulation can lead to pathological conditions such as insulin resistance and cancer.
Key Genes Involved in GO:1901137 carbohydrate derivative biosynthetic process
The following genes encode enzymes and transporters involved in carbohydrate derivative biosynthetic processes, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GFPT1 | Glutamine-fructose-6-phosphate transaminase 1 | Rate-limiting enzyme in hexosamine biosynthesis; linked to glycosylation and metabolic disorders |
| UAP1 | UDP-N-acetylglucosamine pyrophosphorylase 1 | Synthesizes UDP-GlcNAc, a key donor for glycosylation |
| GNE | UDP-N-acetylglucosamine 2-epimerase | Involved in sialic acid biosynthesis; mutations cause sialuria |
| PMM2 | Phosphomannomutase 2 | Defects cause congenital disorder of glycosylation |
| MPI | Mannose-6-phosphate isomerase | Interconverts fructose-6-phosphate and mannose-6-phosphate |
| HK1 | Hexokinase 1 | Phosphorylates glucose, initiating glycolysis and derivative synthesis |
| GPI | Glucose-6-phosphate isomerase | Catalyzes interconversion of glucose-6-phosphate and fructose-6-phosphate |
| PGM1 | Phosphoglucomutase 1 | Converts glucose-1-phosphate to glucose-6-phosphate |
| UGP2 | UDP-glucose pyrophosphorylase 2 | Produces UDP-glucose for glycosylation |
| B4GALT1 | Beta-1,4-galactosyltransferase 1 | Glycosyltransferase involved in glycoconjugate synthesis |
| ST3GAL1 | ST3 beta-galactoside alpha-2,3-sialyltransferase 1 | Sialyltransferase for glycoprotein and glycolipid synthesis |
| FUT8 | Fucosyltransferase 8 | Catalyzes core fucosylation of N-glycans |
| MGAT1 | Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Initiates complex N-glycan formation |
| SLC2A1 | GLUT1 glucose transporter | Facilitates glucose uptake for derivative biosynthesis |
| SLC35A1 | CMP-sialic acid transporter | Transports nucleotide sugars into Golgi for glycosylation |
| SLC35B4 | UDP-xylose and UDP-GlcNAc transporter | Supplies nucleotide sugars to Golgi |
| CHST1 | Carbohydrate sulfotransferase 1 | Adds sulfate groups to carbohydrate derivatives |
| EXT1 | Exostosin glycosyltransferase 1 | Polymerizes heparan sulfate chains |
How Is carbohydrate derivative biosynthetic process Regulated?
Carbohydrate derivative biosynthetic processes are regulated by nutrient availability, hormonal signals, and feedback inhibition. For instance, the hexosamine biosynthetic pathway is sensitive to glucose and glutamine levels, and its end product UDP-GlcNAc regulates protein O-GlcNAcylation, which in turn modulates signaling and transcription. Insulin and other growth factors can influence the expression of enzymes like GFPT1, thereby affecting glycosylation patterns. Additionally, the availability of nucleotide sugar donors in the Golgi is controlled by specific transporters, which can be regulated in response to cellular demand.
carbohydrate derivative biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PMM2 | Congenital disorder of glycosylation type Ia | Knock-in of patient mutations in HEK293 cells |
| GFPT1 | Insulin resistance and diabetes | Knockout in HepG2 cells followed by glucose uptake assay |
| FUT8 | Cancer metastasis and immune evasion | Overexpression in MDA-MB-231 cells for invasion assays |
| GNE | Sialuria and hereditary inclusion body myopathy | Point mutation knock-in in C2C12 myoblasts |
| EXT1 | Hereditary multiple exostoses | Knockout in chondrogenic ATDC5 cells |
Metabolic Disorders
Defects in carbohydrate derivative biosynthesis can lead to metabolic disorders such as congenital disorders of glycosylation (CDG), which present with multisystem symptoms including developmental delay and immune dysfunction. For example, mutations in PMM2 cause CDG-Ia, highlighting the importance of mannose derivative synthesis. Additionally, altered hexosamine pathway flux is implicated in insulin resistance and diabetes.
Cancer
Cancer cells often exhibit aberrant glycosylation, driven by changes in carbohydrate derivative biosynthesis. Increased expression of glycosyltransferases like FUT8 and MGAT1 contributes to tumor progression and metastasis. Targeting these pathways is a potential therapeutic strategy, as glycosylation inhibitors are being explored in clinical trials.
Infectious Diseases
Many pathogens utilize host carbohydrate derivatives for adhesion and entry. For instance, sialic acid derivatives on cell surfaces can serve as receptors for viruses and bacteria. Understanding these interactions can inform the development of anti-adhesion therapies.
Food Science and Nutrition
Carbohydrate derivatives formed during food processing, such as 1,2-dicarbonyl compounds, can have health implications. These compounds are associated with flavor and color but also with potential carcinogenic effects. Moreover, sucrose metabolism impacts sports performance and energy delivery.
From carbohydrate derivative biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of GFPT1 affect glycosylation and insulin signaling? | GFPT1 knockout in HepG2 cells via CRISPR |
| Can a specific point mutation in PMM2 rescue enzyme activity? | Knock-in of wild-type or mutant PMM2 in patient fibroblasts |
| What is the role of FUT8 in tumor metastasis? | FUT8 overexpression in MDA-MB-231 cells |
| How does UDP-GlcNAc transport affect Golgi glycosylation? | SLC35A1 knockout in HeLa cells |
| Does EXT1 haploinsufficiency alter heparan sulfate synthesis? | EXT1 heterozygous knockout in ATDC5 cells |
| Can CRISPR activation upregulate GNE to increase sialic acid production? | CRISPRa of GNE in CHO cells |
How to Study the carbohydrate derivative biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Mass spectrometry | Glycan and nucleotide sugar composition | Profiling glycosylation changes in knockout cells |
| Metabolic labeling | Flux through biosynthetic pathways | Tracing glucose into UDP-GlcNAc |
| Enzymatic assay | Enzyme activity and kinetics | Characterizing mutant glycosyltransferases |
| CRISPR screen | Gene essentiality for glycosylation | Identifying regulators of sialylation |
| Flow cytometry | Cell surface glycan expression | Validating knockout of glycosyltransferases |
| Western blot | Protein expression and glycosylation status | Confirming knockout efficiency |
| Lectin microarray | Glycan binding profiles | Comparing wild-type and mutant cells |
Glycomics and Mass Spectrometry
Mass spectrometry-based glycomics allows comprehensive profiling of carbohydrate derivatives, including nucleotide sugars and glycans. This method can quantify changes in glycosylation patterns following genetic perturbations. It is essential for validating CRISPR models targeting glycosylation genes.
Metabolic Labeling
Metabolic labeling with stable isotopes (e.g., 13C-glucose) enables tracing of carbohydrate derivative fluxes through pathways. This technique can reveal how knockout of specific enzymes alters metabolic flux. It is particularly useful for studying dynamic processes like glycosylation.
Enzymatic Assays
In vitro enzymatic assays using recombinant enzymes and substrates measure the activity of glycosyltransferases and other biosynthetic enzymes. These assays help determine the kinetic parameters and inhibitor sensitivity of target enzymes. They are often used to confirm the impact of point mutations identified in patient samples.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes essential for carbohydrate derivative biosynthesis. For example, a screen for regulators of cell surface sialylation can uncover novel transporters and enzymes. This approach is powerful for discovering new therapeutic targets.
How CRISPR Can Be Used to Study GO:1901137 carbohydrate derivative biosynthetic process
Knockout
CRISPR knockout of genes involved in carbohydrate derivative biosynthesis, such as GFPT1 or UAP1, can abolish specific glycosylation pathways. This allows researchers to study the consequences on cell signaling, adhesion, and metabolism. Knockout models are also used to validate drug targets and understand disease mechanisms.
Point Mutation
Introducing patient-specific point mutations (e.g., in PMM2 or GNE) via CRISPR knock-in enables the study of enzyme dysfunction and genotype-phenotype correlations. These models are valuable for testing pharmacological chaperones or substrate replacement therapies.
Knock-in
Knock-in of tagged versions of glycosyltransferases (e.g., GFP-tagged B4GALT1) allows live-cell imaging and proteomic analysis of enzyme localization and interactions. This approach provides insights into the spatiotemporal regulation of carbohydrate derivative synthesis.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression of genes like FUT8 or ST3GAL1 can enhance specific glycosylation events, mimicking cancer-associated glycan changes. These models are used to study the role of glycosylation in tumor progression and immune evasion.
How EDITGENE Supports carbohydrate derivative biosynthetic process Research
Researchers studying carbohydrate derivative biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in a specific pathway or disease. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic modifications in relevant cell models, accelerating functional validation and therapeutic development.
Contact EDITGENE today to design your custom CRISPR model for carbohydrate derivative biosynthetic process research.
Frequently Asked Questions About carbohydrate derivative biosynthetic process
What is GO:1901137?
GO:1901137 is the Gene Ontology term for carbohydrate derivative biosynthetic process, which describes the chemical reactions and pathways that form carbohydrate derivatives such as sugar phosphates, amino sugars, and nucleotide sugars.
What genes are involved in carbohydrate derivative biosynthetic process?
Key genes include GFPT1, UAP1, GNE, PMM2, MPI, HK1, GPI, PGM1, UGP2, B4GALT1, ST3GAL1, FUT8, MGAT1, SLC2A1, SLC35A1, SLC35B4, CHST1, and EXT1, among others.
Why is carbohydrate derivative biosynthesis important?
It provides essential building blocks for glycoproteins, glycolipids, and polysaccharides, and is critical for cell signaling, metabolism, and immune function. Dysregulation is linked to cancer, diabetes, and infectious diseases.
What diseases are associated with defects in carbohydrate derivative biosynthesis?
Defects can cause congenital disorders of glycosylation, metabolic disorders, cancer progression, and increased susceptibility to infections.
How can CRISPR be used to study carbohydrate derivative biosynthetic process?
CRISPR knockout, knock-in, and overexpression models allow precise manipulation of genes in this pathway to study their functions and roles in disease.
What methods are used to study carbohydrate derivative biosynthesis?
Common methods include mass spectrometry, metabolic labeling, enzymatic assays, flow cytometry, and CRISPR screens.
What is the role of GFPT1 in carbohydrate derivative biosynthesis?
GFPT1 is the rate-limiting enzyme in the hexosamine biosynthetic pathway, controlling UDP-GlcNAc production for glycosylation.
How does sucrose relate to carbohydrate derivative biosynthesis?
Sucrose is a carbohydrate derivative that is metabolized to glucose and fructose, which enter biosynthetic pathways for energy and glycosylation.
Can carbohydrate derivatives affect taste?
Yes, the structural relationships of sugars to taste, including derivatives, influence sweetness perception.
What are potential therapeutic targets in this pathway?
Enzymes like GFPT1, FUT8, and GNE are being explored as targets for metabolic diseases and cancer.
Conclusion
GO:1901137 carbohydrate derivative biosynthetic process encompasses a vital set of metabolic pathways that generate diverse molecules essential for cellular function and organismal health. From nucleotide sugars to glycoconjugates, these derivatives play roles in cell recognition, signaling, and structural integrity. Dysregulation of these pathways is implicated in a range of diseases, including cancer, diabetes, and congenital disorders. Advances in CRISPR technology and analytical methods are enabling precise dissection of these processes, offering new opportunities for therapeutic intervention. Continued research into carbohydrate derivative biosynthesis will undoubtedly yield insights into basic biology and translational applications.
References
- 1. Shin I et al.. 2013. Carbohydrate chemistry.. Chem Soc Rev 42(10):4267-9 PMID: 23598858
- 3. Horváth Z et al.. 2009. Current medical aspects of pantethine.. Ideggyogy Sz 62(7-8):220-9 PMID: 19685700
- 4. MacDonald SL et al.. 1994. Hemoglobin polymerization.. Methods Enzymol 231:287-308 PMID: 8041259
- 5. Birch GG. 1976. Structural relationships of sugars to taste.. CRC Crit Rev Food Sci Nutr 8(1):57-95 PMID: 801349
- 6. Kellam B et al.. 2003. Chemical modification of mammalian cell surfaces.. Chem Soc Rev 32(6):327-37 PMID: 14671788
- 7. Hellwig M et al.. 2018. Food-derived 1,2-dicarbonyl compounds and their role in diseases.. Semin Cancer Biol 49:1-8 PMID: 29174601
- 8. Wallis GA et al.. 2013. Is there a specific role for sucrose in sports and exercise performance?. Int J Sport Nutr Exerc Metab 23(6):571-83 PMID: 23630082
